S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ZVRA Zevra Therapeutics Inc

8.72

0.18 (2.11%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Zevra Therapeutics (NASDAQ:ZVRA)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Zevra Therapeutics Charts.

Zevra Therapeutics (NASDAQ:ZVRA)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Zevra Therapeutics Charts.

Zevra Therapeutics Inc News

Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024
Tuesday 17 December 2024 (6 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 7 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Zevra Therapeutics Announces Organizational Changes
Saturday 7 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Zevra Therapeutics to Participate at Upcoming Investor Conferences
Tuesday 26 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
Friday 22 November 2024 (1 month ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates
Wednesday 13 November 2024 (1 month ago) • GlobeNewswire Inc.

Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13
Wednesday 6 November 2024 (2 months ago) • GlobeNewswire Inc.

More Zevra Therapeutics Inc News Articles

Woodside Petroleum

Verizon Communications

AUD vs US Dollar

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions